Latin-American Guidelines for Cancer Pain Management

References

• Goss PE , LeeBL , Badovinac-CrnjevicTet al. Planning cancer control in Latin America and the Caribbean . Lancet Oncol.14 ( 5 ), 391 – 436 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• UN . Older Persons in Latin America and the Caribbean: Situation and Policies . ECLAC Population Division – Latin American and Caribbean Demographic Centre(CELADE) , Santiago, Chile ( 2003 ).
   Google Scholar
• van den Beuken-van Everdingen MH , de RijkeJM , KesselsAG , SchoutenHC , Van KleefM , PatijnJ . Prevalence of pain in patients with cancer: a systematic review of the past 40 years . Ann. Oncol.18 ( 9 ), 1437 – 1449 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Duthey B , ScholtenW . Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006 . J. Pain Symptom Manage.47 ( 2 ), 283 – 297 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cleary J , De LimaL , EisenchlasJ , RadbruchL , TorodeJ , ChermyNI . Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI) . Ann. Oncol.24 ( 11 ), xi41 – xi50 ( 2013 ).
   PubMedGoogle Scholar
• Knudsen AK , AassN , FainsingerRet al. Classification of pain in cancer patients – a systematic literature review . Palliat. Med.23 ( 4 ), 295 – 308 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Haugen DF , HjermstadMJ , HagenN , CaraceniA , KaasaS , European Palliative Care Research Collaborative (EPCRC) . Assessment and classification of cancer breakthrough pain: a systematic literature review . Pain149 ( 3 ), 476 – 482 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Caraceni A , PortenoyRK . An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain . Pain82 ( 3 ), 263 – 274 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Caraceni A , DaviesA , PoulainP , Cortés-FunesH , PanchalSJ , FanelliG . Guidelines for the management of breakthrough pain in patients with cancer . J. Natl Compr. Canc. Netw.11 ( Suppl. 1 ), S29 – S36 ( 2013 ).
   PubMedGoogle Scholar
• Narayana A , KatzN , ShillingtonACet al. National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomes . Pain156 , 252 – 259 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• International Association for the Study of Pain Breakthrough Pain in Cancer Patients . Pain Clinical Updates IASP ( 2006 ). http://iasp.files.cms-plus.com/Content/ContentFolders/Publications2/PainClinicalUpdates/Archives/PCU06-1_1390263807201_21.pdf .
   Google Scholar
• Paice JA , FerrellB . The management of cancer pain . CA Cancer J. Clin.61 ( 3 ), 157 – 182 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Scottish Intercollegiate Guidelines Network Control of pain in patients with cancer ( 2007 ). www.sign.ac.uk .
   Google Scholar
• British Pain Society . Cancer Pain Management 2010 . www.britishpainsociety.org .
   Google Scholar
• Cid J , AcuñaJP , De AndrésJ , DíazL , Gómez-CaroL . ¿Qué y cómo evaluar al paciente con dolor crónico? Evaluación del paciente con dolor crónico . Rev. Med. Clin. Condes.25 ( 4 ), 687 – 697 ( 2014 ).
   Google Scholar
• Serrano Atero MS , CaballeroJ , CañasA , Garcia-SauraPL , Serrano-Alvarez , PrietoJ . Valoración del dolor (II) . Rev. Soc. Esp. Dolor.9 , 109 – 121 ( 2002 ).
   Google Scholar
• Kumar SP . Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review . Indian J. Palliat. Care17 ( 2 ), 108 – 115 ( 2011 ).
   PubMedGoogle Scholar
• Miró J . Evaluación de la intensidad del dolor en el paciente con cáncer . Psicooncología9 ( 2–3 ), 393 – 401 ( 2012 ).
   Google Scholar
• Ngamkham S , VincentC , FinneganL , HoldenJE , WangZJ , WilkieDJ . The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review . Pain Manag. Nurs.13 ( 1 ), 27 – 51 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Badia X , MurielC , GraciaAet al. Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica . Med. Clin. (Barc)120 ( 2 ), 52 – 59 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bennett MI , RaymentC , HjermstadM , AassN , CaraceniA , KaasaS . Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review . Pain153 ( 2 ), 359 – 365 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mercadante S , GebbiaV , DavidFet al. Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients . J. Pain10 ( 6 ), 594 – 600 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Portenoy RK , HagenNA . Breakthrough pain: definition, prevalence and characteristics . Pain41 , 273 – 281 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Davies AN , DickmanA , ReidC , StevensAM , ZeppetellaG . Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland . Eur. J. Pain13 ( 4 ), 331 – 338 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Portenoy RK , ForbesK , LussierD , HangsG . Difficult pain problems: an integrated approach . In : Oxford Textbook of Palliative Medicine (3rd Edition) . DoyleD , HanksG , ChernyN , CalmenK ( Eds ). Oxford University Press , Oxford, UK , 1438 – 1458 ( 2004 ).
   Google Scholar
• Coluzzi PH . Cancer pain management: newer perspectives on opioids and episodic pain . Am. J. Hosp. Palliat. Care15 ( 1 ), 13 – 22 ( 1998 ).
   PubMedGoogle Scholar
• Nabal M , MadridF . Dolor episódico: definición, etiología y epidemiología . Rev. Soc. Esp. Dolor9 , 88 – 93 ( 2002 ).
   Google Scholar
• Pergolizzi JV , GhariboC , HoKY . Treatment considerations for cancer pain: a global perspective . Pain Pract.15 ( 8 ), 778 – 792 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Escobar Álvarez Y , Biete i SolàA , Camba RodríguezMet al. Diagnóstico y tratamiento del dolor irruptivo oncológico: recomendaciones de consenso . Rev. Soc. Esp. Dolor21 ( 2 ), 97 – 105 ( 2014 ).
   Google Scholar
• Mercadante S . Breakthrough pain in cancer patients: prevalence, mechanisms and treatment options . Curr. Opin. Anaesthesiol.28 ( 5 ), 559 – 564 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Working Group Nientemale DEI , VellucciR , FanelliGet al.What to do, and what not to do, when diagnosing and treating breakthrough cancer pain (BTcP): expert opinion . Drugs76 ( 3 ), 315 – 330 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zeppetella G , RibeiroMD . Opioids for the management of the breakthrough (episodic) pain in cancer patients . Cochrane Database Syst. Rev.25 ( 1 ), CD004311 ( 2006 ).
   Google Scholar
• Zeppetella G . Breakthrough pain in cancer patients . Clin. Oncol.23 ( 6 ), 393 – 398 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Eisenberg E , MarinangeliF , BirkhahnJ , PaladiniA , VarrassiG . Time to modify the WHO analgesic ladder?Pain Clinical Updates (IASP Press)13 ( 5 ), 1 – 4 ( 2005 ).
   Google Scholar
• Mair J . Is the WHO analgesic ladder active or archaic?Eur. J. Palliat. Care15 ( 4 ), 162 – 165 ( 2008 ).
   Google Scholar
• Caraceni A , HanksG , KaasaSet al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC . Lancet Oncol.13 , e58 – e68 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Marinangeli F , CiccozziA , LeonardisMet al. Use of strong opioids in advanced cancer pain: a randomized trial . J. Pain Symptom Manage.27 , 409 – 416 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Vadalouca A , RaptisE , MokaE , AisP , SykiotiP , SiafakaI . Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature . Pain Pract.12 ( 3 ), 219 – 251 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Cleary JF . The pharmacologic management of cancer pain . J. Palliat. Med.10 ( 6 ), 1369 – 1394 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network NCCN ( 2015 ). Clinical Practice Guidelines in Oncology (NCCN Guidelines Adult Cancer Pain Version 2) . www.nccn.org/professionals/physician_gls/f_guidelines.asp .
   Google Scholar
• Chou R , CrucianiRA , FiellinDAet al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society . J. Pain15 ( 4 ), 321 – 337 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bandieri E , RomeroM , RipamontiCIet al. Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain . J. Clin. Oncol.34 ( 5 ), 436 – 442 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration . Information for Healthcare Professionals: Fentanyl Transdermal System (marketed as Duragesic and generics) – 12/21/2007 Update . www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm084307.htm .
   Google Scholar
• Good P , AfsharimaniB , MovvaR , HaywoodA , KhanS , HardyJ . Therapeutic challenges in cancer pain management: a systematic review of methadone . J. Pain Palliat. Care Pharmacother.28 ( 3 ), 197 – 205 ( 2014 ).
   PubMedGoogle Scholar
• Vignaroli E , BennettMI , NekolaichukCet al. Strategic pain management: the identification and development of the IAHPC opioid essential prescription package . J. Palliat. Med.15 ( 2 ), 186 – 191 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Afsharimani B , KindlK , GoodP , HardyJ . Pharmacological options for the management of refractory cancer pain-what is the evidence?Support Care Cancer23 ( 5 ), 1473 – 1481 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hernández Ortiz A . Equianalgésica y rotación de opioides en el perioperatorio . Revista Mexicana de Anestesiología38 ( 1 ), 172 – 174 ( 2015 ).
   Google Scholar
• Fine PG , PortenoyRK , Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation . Establishing “best practices” for opioid rotation: conclusions of an expert panel . J. Pain Symptom Manage.38 , 418 – 425 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Mercadante S , CaraceniA . Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review . Palliat. Med.25 ( 5 ), 504 – 515 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Davis M , WalshD , LagmanR , LeGrandSB . Controversies in pharmacotherapy of pain management . Lancet Oncol.6 ( 9 ), 696 – 704 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Aapro M , SaadF , CostaL . Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases . Oncologist15 ( 11 ), 1147 – 1158 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Smith TJ , SaikiCB . Cancer pain management . Mayo Clin. Proc.90 ( 10 ), 1428 – 1439 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lutz S , BerkL , ChangEet al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline . Int. J. Radiat. Onco. Biol. Phys.79 ( 4 ), 965 – 976 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Roqué I Figuls M , Martinez-ZapataMJ , Scott-BrownM , Alonso-CoelloP . Radioisotopes for metastatic bone pain . Cochrane Database Syst. Rev. ( 7 ), CD003347 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ripamonti CI , SantiniD , MaranzanoE , BertiM , RoilaF , ESMO Guidelines Working Group . Management of cancer pain: ESMO Clinical Practice Guidelines . Ann. Oncol.23 ( Suppl. 7 ), vii139 – vii154 ( 2012 ).
   PubMed Web of Science ®Google Scholar